UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. _________)*
Gish Biomedical Incorporated
------------------------------------------------------------------
(Name of Issuer)
Common Stock
------------------------------------------------------------------
(Title of Class of Securities)
376360103
---------------------------
(CUSIP Number)
Check the following line if a fee is being paid with this
settlement ____. (A fee is not required only if the filing
person: (1) has a previous statement on file reporting
beneficial ownership of more than five percent of the class
of securities described in Item 1; and (2) has filed no
amendment subsequent thereto reporting beneficial ownership
of five percent or less of such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect
to the subject class of securities, and for any subsequent
amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section
18 of the Securities Exchange Act of 1934 ("Act") or
otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act
(however, see the Notes).
Page 1 of 5
<PAGE>
CUSIP No. 376360103 13G Page 2 of 5
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Shawmut National Corporation (#06-1212629)
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE LINE IF A MEMBER OF A GROUP*
(a)______
(b)__X__
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
State of Connecticut/United States of America
-------------------------------------------------------------------
5. SOLE VOTING POWER
NUMBER OF 126,000 Shares
SHARES
-------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY None
EACH
-------------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON 151,000 Shares
WITH
-------------------------------------------------------
8. SHARED DISPOSITIVE POWER
0 Shares
-------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
151,000 Shares
-------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES*
-------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.0%
-------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
HC, BK
-------------------------------------------------------------------
* SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
Page 3 of 5
Item 1(a). Name of Issuer.
Gish Biomedical Incorporated
Item 1(b). Address of Issuer's Principal Executive
Offices.
2681 Kelvin Avenue
Irvine, CA 92174
Item 2(a). Name of Person Filing.
Shawmut National Corporation
Item 2(b). Address of Principal Business Office.
777 Main Street, Hartford, CT 06115
Item 2(c). Citizenship.
United States of America
Item 2(d). Title of Class of Securities.
Common Stock
Item 2(e). CUSIP Number.
376360 10 3
Item 3. Statements Filed Pursuant to Rule 13d-1(b) or
13d-2(b).
The person filing is a:
(b) X Bank has defined in Section 3(a)(b) of
the Act
(g) X Parent Holding Company, in accordance
with s240.13d-1(b)(ii)(G)
Item 4. Ownership. (See Item 6)
(a) Amount beneficially owned (as of
December 31, 1993: 151,000 shares.)
(b) Percent of class: 5.0%
<PAGE>
Page 4 of 5
(c) Number of shares as to which such person
has:
(i) Sole power to vote or to direct
the vote 126,000 shares
(ii) Shared power to vote or to direct
the vote no shares
(iii) Sole power to dispose or to direct
the disposition of 151,000 shares
(iv) Shared power to dispose on to direct
the disposition of 0 shares
Item 5. Ownership of Five Percent of Less of a Class.
Not applicable
Item 6. Ownership of More Than Five Percent on Behalf
of Another Person.
All of the shares reported as beneficially
owned under Item 4(a), above, are held by the
Bank in a fiduciary capacity. Shares are
held by the Bank as trustee, and/or
Co-Trustee, for the benefit of other persons
who have the right to receive dividends and
the proceeds from the sale of such shares.
Item 7. Identification and Classification of the
Subsidiary Which Acquired the Security Being
Reported on by the Parent Holding Company.
Shawmut Bank Connecticut, N.A.
Shawmut Bank, N.A.
Item 3 classification: (b) Bank as defined
in Section 3(a)(6) of the Act.
Item 8. Identification and Classification of Members
of the Group.
Not applicable.
<PAGE>
Page 5 of 5
Item 10. Certification.
By signing below we certify that, to the best
of our knowledge and belief, the securities
referred to above were acquired in the
ordinary course of business and were not
acquired for the purpose of and do not have
the affect of changing or influencing the
control of the issuer of such securities were
not acquired in connection with or as a
participant in any transaction having such
purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of our knowledge
and belief, we certify that the information set forth
in this statement is true, complete and correct.
SHAWMUT NATIONAL CORPORATION
Date: January 31, 1994 By (Gunnar S. Overstrom) President/COO
--------------------------------------
(Name) (Title)
